← Back to Search

Procedure

Treatment for Burns (CELLMIST1 Trial)

Phase 1
Waitlist Available
Research Sponsored by RenovaCare, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the evaluation will include all reported secondary surgical interventions for the period from enrollment and up to 12 months
Awards & highlights

CELLMIST1 Trial Summary

This trial is testing a new way to treat deep second degree burns. The goal is to see if it is safe.

Eligible Conditions
  • Burns

CELLMIST1 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the evaluation will include all reported secondary surgical interventions for the period from enrollment and up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and the evaluation will include all reported secondary surgical interventions for the period from enrollment and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
All Adverse Events
Secondary Surgical Interventions

Find a Location

Who is running the clinical trial?

RenovaCare, IncLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025